Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAOI Applied Optoelectronics	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Genovese Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.11 +39.3%	$36.00 ➝ $36.00	Buy ➝ Buy
AAPL Apple	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	$213.49 +1.8%	$325.00 ➝ $325.00	Outperform ➝ Outperform
ABNB Airbnb	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$122.86 +2.9%	$195.00 ➝ $200.00	Buy ➝ Buy
ACIU AC Immune	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.29 -0.4%	$16.00 ➝ $16.00	Buy ➝ Buy
ACN Accenture	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Ramnani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$318.28 +0.4%	$429.00 ➝ $396.00	Overweight ➝ Overweight
AEO American Eagle Outfitters	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Nardone Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.06 +0.7%	$18.00 ➝ $13.00	Neutral ➝ Neutral
AFCG AFC Gamma	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hurwit Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.62 -2.1%	$10.00 ➝ $7.00	Buy ➝ Hold
AKBA Akebia Therapeutics	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Allison Bratzel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.26 +33.7%	$4.00 ➝ $6.00	Overweight ➝ Overweight
AKBA Akebia Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ed Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.26 +33.7%	$7.50 ➝ $7.50	Buy ➝ Buy
ALAB Astera Labs	Initiated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the recommendation accuracy rating	$72.18 +10.5%	$82.00	Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ALLO Allogene Therapeutics	Upgraded by	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Benjamin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.94 +2.6%	$5.00	Market Perform ➝ Outperform
ALLO Allogene Therapeutics	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Newman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.94 +2.6%	$14.00 ➝ $14.00	Buy ➝ Buy
ALLO Allogene Therapeutics	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Luca Issi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.94 +2.6%	$10.00 ➝ $10.00	Outperform ➝ Outperform
ALT Altimmune	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Hsieh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.92 +13.8%		Market Perform
AMD Advanced Micro Devices	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$100.97 +2.9%	$140.00 ➝ $120.00	Outperform ➝ Outperform
AMTX Aemetis	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Amit Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.68 +5.7%	$28.00 ➝ $28.00	Buy ➝ Buy
ANIP ANI Pharmaceuticals	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Glen Santangelo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$62.49 +1.7%	$80.00	Buy
APD Air Products and Chemicals	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Spector Subscribe to MarketBeat All Access for the recommendation accuracy rating	$291.82 -0.4%	$395.00 ➝ $370.00	Buy ➝ Buy
ARCB ArcBest	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jordan Alliger Subscribe to MarketBeat All Access for the recommendation accuracy rating	$73.35 +0.4%	$126.00 ➝ $108.00	Neutral ➝ Neutral
ATAT Atour Lifestyle	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Leung Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.25 +5.5%	$35.30 ➝ $36.80	Buy ➝ Buy
ATYR Atyr PHARMA	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.97 -0.5%	$35.00 ➝ $35.00	Buy ➝ Buy
AVAH Aveanna Healthcare	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.19 +1.0%	$3.20 ➝ $4.50	Sell ➝ Sell
AVNT Avient	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.33 +2.1%	$43.00	Neutral
AVNT Avient	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Panjabi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.33 +2.1%		Hold
AXP American Express	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. George Subscribe to MarketBeat All Access for the recommendation accuracy rating	$266.04 +3.7%		Strong Sell ➝ Hold
AXP American Express	Upgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	David George Subscribe to MarketBeat All Access for the recommendation accuracy rating	$266.04 +3.7%	$265.00 ➝ $265.00	Underperform ➝ Neutral
BBW Build-A-Bear Workshop	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.42 +3.0%	$50.00 ➝ $50.00	Buy ➝ Buy
BLDP Ballard Power Systems	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ameet Thakkar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.32 +3.1%	$1.30 ➝ $1.20	Underperform ➝ Underperform
BLDP Ballard Power Systems	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Irwin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.32 +3.1%	$1.75 ➝ $1.25	Neutral ➝ Neutral
BLDP Ballard Power Systems	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.32 +3.1%	$2.50 ➝ $2.00	Market Perform
BLDP Ballard Power Systems	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.32 +3.1%	$1.90 ➝ $1.40	Hold
BLDP Ballard Power Systems	Target Lowered by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.32 +3.1%	$2.60 ➝ $2.00	Sector Perform
BLNK Blink Charging	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mickey Legg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.95 +6.0%	$5.00 ➝ $2.00	Buy ➝ Buy
BLNK Blink Charging	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Irwin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.95 +6.0%	$4.00 ➝ $3.00	Buy ➝ Buy
BLNK Blink Charging	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Pierce Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.95 +6.0%		Hold ➝ Hold
BLNK Blink Charging	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sameer Joshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.95 +6.0%	$8.00 ➝ $8.00	Buy ➝ Buy
BXP Boston Properties	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Anthony Powell Subscribe to MarketBeat All Access for the recommendation accuracy rating	$65.55 +2.5%	$89.00 ➝ $79.00	Equal Weight ➝ Equal Weight
CAAP Corporación América Airports	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Guilherme Mendes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.43 +2.8%	$22.50	Overweight
CADL Candel Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vernon Bernardino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.75 +10.2%	$19.00 ➝ $19.00	Buy ➝ Buy
CCI Crown Castle	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ric Prentiss Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.20 +8.5%	$128.00 ➝ $122.00	Outperform ➝ Strong-Buy
Your Wealth is Under Attack (Ad) Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now. Get Your FREE Presidential Transition Guide Today
CCI Crown Castle	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brandon Nispel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.20 +8.5%	$120.00	Sector Weight ➝ Overweight
CCI Crown Castle	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Batya Levi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.20 +8.5%	$118.00 ➝ $118.00	Neutral ➝ Buy
CCI Crown Castle	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Maher Yaghi Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.20 +8.5%	$102.00 ➝ $99.00	Sector Perform ➝ Sector Perform
CCI Crown Castle	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the recommendation accuracy rating	$103.20 +8.5%	$106.00 ➝ $108.00	Buy ➝ Buy
CCL Carnival Co. &	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Wieczynski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.93 +4.2%	$34.00 ➝ $30.00	Buy ➝ Buy
CCLD CareCloud	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.47 -8.1%	$3.50 ➝ $1.50	Neutral ➝ Neutral
CCRN Cross Country Healthcare	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Steinke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.58 -1.1%	$18.61 ➝ $18.61	Market Perform ➝ Market Perform
CHE Chemed	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the recommendation accuracy rating	$598.15 +1.4%	$633.00 ➝ $667.00	Outperform ➝ Outperform
CHKP Check Point Software Technologies	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Nowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$224.84 +4.6%	$200.00 ➝ $280.00	Equal Weight ➝ Overweight
CHTR Charter Communications	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Rollins Subscribe to MarketBeat All Access for the recommendation accuracy rating	$351.50 +1.8%	$425.00	Buy
CL Colgate-Palmolive	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.80 -0.8%	$97.00 ➝ $99.00	Overweight ➝ Overweight
CMG Chipotle Mexican Grill	Upgraded by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alton Stump Subscribe to MarketBeat All Access for the recommendation accuracy rating	$50.12 +2.8%	$58.00 ➝ $65.00	Hold ➝ Buy
CNTY Century Casinos	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steven Wieczynski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.90 -0.5%	$5.00 ➝ $4.00	Buy ➝ Buy
CNTY Century Casinos	Target Lowered by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chad Beynon Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.90 -0.5%	$6.00 ➝ $5.00	Outperform ➝ Outperform
COMP Compass	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bernie McTernan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.74 +0.1%	$12.00 ➝ $12.00	Buy ➝ Buy
COR Cencora	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$258.09 +0.8%	$251.00 ➝ $274.00	Equal Weight ➝ Equal Weight
CPRT Copart	Downgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Staszak Subscribe to MarketBeat All Access for the recommendation accuracy rating	$52.65 +0.7%		Buy ➝ Hold
CTRE CareTrust REIT	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.35 +2.3%	$26.00 ➝ $26.00	Underperform ➝ Underperform
CURV Torrid	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.02 +4.7%	$5.00 ➝ $5.00	Market Perform ➝ Market Perform
CVNA Carvana	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael McGovern Subscribe to MarketBeat All Access for the recommendation accuracy rating	$181.37 +8.8%	$270.00 ➝ $220.00	Buy ➝ Buy
DG Dollar General	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Robert Ohmes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$79.15 -1.0%	$95.00 ➝ $90.00	Buy ➝ Buy
DG Dollar General	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$79.15 -1.0%	$79.00 ➝ $81.00	Neutral ➝ Neutral
DHR Danaher	Upgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Arias Subscribe to MarketBeat All Access for the recommendation accuracy rating	$211.09 +3.4%	$260.00	Hold ➝ Buy
DINO HF Sinclair	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Connor Lynagh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.36 +4.3%	$51.00 ➝ $50.00	Overweight ➝ Overweight
DINO HF Sinclair	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$32.36 +4.3%	$37.00 ➝ $35.00	Equal Weight ➝ Equal Weight
DK Delek US	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Connor Lynagh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.66 +7.1%	$19.00 ➝ $18.00	Underweight ➝ Underweight
DKS DICK'S Sporting Goods	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$194.74 +4.4%	$250.00 ➝ $250.00	Outperform ➝ Outperform
DLTH Duluth	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Komp Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.28 -9.9%	$3.50 ➝ $2.75	Neutral ➝ Neutral
DOCU DocuSign	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.76 +14.8%	$70.00 ➝ $73.00	Underweight ➝ Underweight
DOCU DocuSign	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.76 +14.8%	$100.00 ➝ $100.00	Neutral ➝ Neutral
DOCU DocuSign	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.76 +14.8%	$100.00 ➝ $90.00	Neutral ➝ Neutral
DOCU DocuSign	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.76 +14.8%	$113.00 ➝ $115.00	Buy ➝ Buy
DOCU DocuSign	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.76 +14.8%	$90.00 ➝ $90.00	Sector Perform ➝ Sector Perform
DOCU DocuSign	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.76 +14.8%		Hold ➝ Hold
DOCU DocuSign	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.76 +14.8%	$112.00 ➝ $98.00	Neutral ➝ Neutral
EFX Equifax	Downgraded by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Grobler Subscribe to MarketBeat All Access for the recommendation accuracy rating	$235.96 -0.3%	$265.00	Outperform ➝ Neutral
EPAC Enerpac Tool Group	Initiated by	CJS Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Moore Subscribe to MarketBeat All Access for the recommendation accuracy rating	$44.06 +3.6%	$53.00	Outperform
EPD Enterprise Products Partners	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$33.54 +1.7%	$35.00 ➝ $37.00	Overweight ➝ Overweight
ETNB 89bio	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrea Newkirk Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.47 +3.5%	$11.00	Neutral
EVCM EverCommerce	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.36 +4.6%	$13.00 ➝ $12.00	Outperform ➝ Outperform
EVCM EverCommerce	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Macwilliams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.36 +4.6%	$12.00 ➝ $9.00	Equal Weight ➝ Equal Weight
EVCM EverCommerce	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gabriela Borges Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.36 +4.6%	$9.00 ➝ $8.00	Sell ➝ Sell
EVCM EverCommerce	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.36 +4.6%	$14.00 ➝ $11.00	Outperform ➝ Outperform
EVCM EverCommerce	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Samad Samana Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.36 +4.6%	$12.00 ➝ $10.00	Hold ➝ Hold
EVEX EVE	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.19 -2.9%	$5.00 ➝ $5.00	Overweight ➝ Overweight
FLWS 1-800-FLOWERS.COM	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Linda Bolton Weiser Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.84 -3.2%	$7.50 ➝ $7.50	Neutral ➝ Neutral
FMBH First Mid Bancshares	Target Lowered by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.45 +1.3%	$48.00 ➝ $43.00	Outperform
FMX Fomento Económico Mexicano	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rodrigo Alcantara Subscribe to MarketBeat All Access for the recommendation accuracy rating	$99.04 +1.4%	$94.00 ➝ $107.00	Neutral ➝ Neutral
FN Fabrinet	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Genovese Subscribe to MarketBeat All Access for the recommendation accuracy rating	$220.85 -1.3%	$285.00 ➝ $285.00	Buy ➝ Buy
FUN Cedar Fair	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brandt Montour Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.88 +8.0%	$41.00	Overweight
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up.
FUTU Futu	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Katherine Lei Subscribe to MarketBeat All Access for the recommendation accuracy rating	$118.47 +10.2%	$160.00 ➝ $170.00	Overweight ➝ Overweight
FVR FrontView REIT	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Kilichowski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.52 +0.2%	$20.00 ➝ $19.00	Overweight ➝ Overweight
GBIO Generation Bio	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.48 -6.3%	$5.00	Outperform
GBIO Generation Bio	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.48 -6.3%	$8.00 ➝ $8.00	Buy ➝ Buy
GDOT Green Dot	Upgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Sutton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.73 +16.3%	$14.00	Hold ➝ Buy
GIII G-III Apparel Group	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.67 +2.2%	$38.00 ➝ $30.00	Market Perform ➝ Market Perform
GIS General Mills	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Thomas Palmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.53 -0.5%	$60.00 ➝ $58.00	Neutral ➝ Neutral
GOSS Gossamer Bio	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.45 +11.5%	$4.00 ➝ $4.00	Outperform ➝ Outperform
GRPN Groupon	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Sheridan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.85 -0.1%	$8.00 ➝ $9.00	Sell ➝ Sell
HAIN The Hain Celestial Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ken Goldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.82 -12.0%	$6.00 ➝ $5.00	Neutral ➝ Neutral
HGBL Heritage Global	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Argento Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.36 +12.9%	$5.00 ➝ $4.00	Buy ➝ Buy
HQY HealthEquity	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$97.41 +3.7%	$112.00 ➝ $112.00	Outperform ➝ Outperform
HSY Hershey	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$170.32 -0.9%	$125.00 ➝ $132.00	Underweight ➝ Underweight
INAB IN8bio	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.23 -0.4%	$8.00 ➝ $6.00	Buy ➝ Buy
INSE Inspired Entertainment	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Scharf Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.37 +4.2%	$14.00	Market Outperform ➝ Market Outperform
INSE Inspired Entertainment	Target Set by	New Street Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Bain Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.37 +4.2%	$21.00
INSE Inspired Entertainment	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Barry Jonas Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.37 +4.2%	$19.00
IPA ImmunoPrecise Antibodies	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.38 -5.0%	$7.00 ➝ $7.00	Buy ➝ Buy
KALV KalVista Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$12.60 +2.9%	$20.00 ➝ $20.00	Buy ➝ Buy
KLTR Kaltura	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.85 -1.1%	$3.00 ➝ $3.00	Buy ➝ Buy
LDI loanDepot	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Douglas Harter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.39 +1.1%	$2.00 ➝ $1.35	Neutral ➝ Neutral
LRN Stride	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alexander Paris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.93 +2.1%	$140.00 ➝ $140.00	Outperform ➝ Outperform
LYRA Lyra Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.17 -1.7%	$2.00 ➝ $2.00	Neutral ➝ Neutral
MANH Manhattan Associates	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	George Kurosawa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$172.50 +5.5%	$244.00 ➝ $184.00	Neutral ➝ Neutral
MANH Manhattan Associates	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinton Gabrielli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$172.50 +5.5%	$268.00 ➝ $200.00	Overweight ➝ Overweight
MC Moelis & Company	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.61 +1.8%	$86.00 ➝ $75.00	Neutral ➝ Neutral
MCK McKesson	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$650.96 +1.1%	$641.00 ➝ $691.00	Equal Weight ➝ Equal Weight
MCRB Seres Therapeutics	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris Shibutani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.69 +8.1%	$1.00 ➝ $0.75	Sell ➝ Sell
MNOV MediciNova	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.55 +5.4%	$9.00 ➝ $9.00	Buy ➝ Buy
MNTK Montauk Renewables	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Manav Gupta Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.07 -16.9%	$6.25 ➝ $3.00	Neutral ➝ Neutral
MNTK Montauk Renewables	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Pfingst Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.07 -16.9%	$4.00 ➝ $3.00	Neutral ➝ Neutral
MPC Marathon Petroleum	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$141.23 +3.1%	$159.00 ➝ $161.00	Overweight ➝ Overweight
MPLX Mplx	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$53.43 +2.0%	$52.00 ➝ $55.00	Overweight ➝ Overweight
MYRG MYR Group	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Sangita Jain Subscribe to MarketBeat All Access for the recommendation accuracy rating	$117.21 +5.0%	$136.00	Sector Weight ➝ Overweight
NABL N-able	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Vandrick Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.61 -3.0%	$8.75 ➝ $9.00	Sector Perform ➝ Sector Perform
NABL N-able	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.61 -3.0%		Outperform
NABL N-able	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.61 -3.0%	$10.00 ➝ $10.00	Buy ➝ Buy
NCMI National CineMedia	Upgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alicia Reese Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.95 +4.2%	$7.50 ➝ $7.50	Neutral ➝ Outperform
NCMI National CineMedia	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Sholl Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.95 +4.2%	$7.00 ➝ $7.00	Outperform ➝ Outperform
NET Cloudflare	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Borges Subscribe to MarketBeat All Access for the recommendation accuracy rating	$115.83 +1.9%	$183.00 ➝ $161.00	Buy ➝ Buy
NKTR Nektar Therapeutics	Upgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jay Olson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.90 +10.0%	$6.00	Market Perform ➝ Outperform
NOTE FiscalNote	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.91 -5.7%	$3.00 ➝ $2.00	Buy ➝ Buy
NOTE FiscalNote	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Zach Cummings Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.91 -5.7%	$1.75 ➝ $1.50	Buy ➝ Buy
NRXP NRx Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vernon Bernardino Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.35 +13.5%	$19.00 ➝ $19.00	Buy ➝ Buy
NUVL Nuvalent	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Dai Subscribe to MarketBeat All Access for the recommendation accuracy rating	$77.01 +3.4%	$100.00 ➝ $100.00	Neutral ➝ Buy
NVDA NVIDIA	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$121.67 +5.3%	$175.00 ➝ $168.00	Outperform ➝ Outperform
NVMI Nova	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Prisco Subscribe to MarketBeat All Access for the recommendation accuracy rating	$219.13 +1.8%	$315.00 ➝ $300.00	Overweight ➝ Overweight
NYXH Nyxoah	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.51 +4.6%	$16.00 ➝ $15.00	Buy ➝ Buy
PATH UiPath	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.84 +8.8%	$16.00 ➝ $11.50	Market Perform ➝ Market Perform
PBF PBF Energy	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Connor Lynagh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$20.70 +5.2%	$31.00 ➝ $28.00	Equal Weight ➝ Equal Weight
A market crash is coming—here’s when (Ad) The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical. Click here to check out my full write-up.
PD PagerDuty	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.41 +17.9%	$24.00 ➝ $22.00	Outperform ➝ Outperform
PD PagerDuty	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joel Fishbein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.41 +17.9%	$30.00 ➝ $26.00	Buy ➝ Buy
PD PagerDuty	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.41 +17.9%	$24.00 ➝ $23.00	Buy ➝ Buy
PD PagerDuty	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.41 +17.9%	$21.00 ➝ $18.00	Neutral ➝ Neutral
PEN Penumbra	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Travis Steed Subscribe to MarketBeat All Access for the recommendation accuracy rating	$273.51 +4.9%	$320.00	Buy
PGR Progressive	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the recommendation accuracy rating	$283.87 +1.6%	$275.00 ➝ $285.00	Neutral ➝ Neutral
PHAR Pharming Group	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.77 +0.3%	$37.00 ➝ $37.00	Buy ➝ Buy
PHAR Pharming Group	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Carrier Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.77 +0.3%	$30.00 ➝ $39.00	Outperform ➝ Outperform
PIPR Piper Sandler Companies	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Yaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$254.06 +0.8%	$321.00 ➝ $286.00	Neutral ➝ Neutral
PIPR Piper Sandler Companies	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Yaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$254.06 +0.8%	$321.00 ➝ $286.00	Neutral ➝ Neutral
PM Philip Morris International	Upgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Coleman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$151.95 +1.0%		Hold ➝ Buy
PRKS United Parks & Resorts	Initiated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brandt Montour Subscribe to MarketBeat All Access for the recommendation accuracy rating	$47.71 +4.5%	$50.00	Equal Weight
PRQR ProQR Therapeutics	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keay Nakae Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.69 -2.9%	$4.00 ➝ $4.00	Buy ➝ Buy
PRQR ProQR Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.69 -2.9%	$10.00 ➝ $12.00	Buy ➝ Buy
PSX Phillips 66	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$126.84 +3.5%	$115.00 ➝ $135.00	Equal Weight ➝ Equal Weight
PTCT PTC Therapeutics	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Joseph Subscribe to MarketBeat All Access for the recommendation accuracy rating	$54.50 +3.3%	$72.00 ➝ $78.00	Overweight ➝ Overweight
PTON Peloton Interactive	Upgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.05 +16.1%	$10.00	Hold ➝ Buy
PWP Perella Weinberg Partners	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Yaro Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.48 -0.8%	$23.00 ➝ $20.00	Sell ➝ Sell
QBTS D-Wave Quantum	Target Raised by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Suji Desilva Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.19 +47.4%	$7.00 ➝ $10.00	Buy ➝ Buy
QBTS D-Wave Quantum	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Williams Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.19 +47.4%	$8.00 ➝ $8.00	Buy ➝ Buy
QBTS D-Wave Quantum	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.19 +47.4%	$8.50 ➝ $8.50	Buy ➝ Buy
QBTS D-Wave Quantum	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Ellis Subscribe to MarketBeat All Access for the recommendation accuracy rating	$10.19 +47.4%	$11.00 ➝ $12.00	Buy ➝ Buy
RBRK Rubrik	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.54 +27.6%	$72.00 ➝ $77.00	Outperform ➝ Outperform
RBRK Rubrik	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ruykhaver Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.54 +27.6%	$85.00 ➝ $85.00	Overweight ➝ Overweight
RBRK Rubrik	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Nowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.54 +27.6%	$76.00 ➝ $80.00	Overweight ➝ Overweight
RBRK Rubrik	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.54 +27.6%	$75.00 ➝ $80.00	Outperform ➝ Outperform
RBRK Rubrik	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.54 +27.6%	$83.00 ➝ $87.00	Overweight ➝ Overweight
RBRK Rubrik	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the recommendation accuracy rating	$70.54 +27.6%	$87.00 ➝ $82.00	Overweight ➝ Overweight
RC Ready Capital	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Douglas Harter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.02 -0.9%	$7.00 ➝ $5.00	Neutral ➝ Neutral
RELX Relx	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Julien Roch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$48.99 +2.5%		Equal Weight ➝ Overweight
RGLS Regulus Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.48 +7.2%	$10.00 ➝ $10.00	Buy ➝ Buy
RGNX REGENXBIO	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniil Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.72 +2.6%	$52.00 ➝ $52.00	Buy ➝ Buy
RGNX REGENXBIO	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Judah Frommer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.72 +2.6%	$22.00 ➝ $24.00	Overweight ➝ Overweight
RNAC Cartesian Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mitchell Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.80 -4.9%	$45.00 ➝ $40.00	Buy ➝ Buy
RVLV Revolve Group	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Randal Konik Subscribe to MarketBeat All Access for the recommendation accuracy rating	$22.27 +4.7%	$30.00	Hold ➝ Buy
SANA Sana Biotechnology	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Roger Song Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.93 +10.6%	$7.00	Buy
SARO StandardAero	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kristine Liwag Subscribe to MarketBeat All Access for the recommendation accuracy rating	$28.60 -1.3%	$33.00 ➝ $32.00	Equal Weight ➝ Equal Weight
SKLZ Skillz	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.40 -14.0%	$15.00	Outperform
SKWD Skyward Specialty Insurance Group	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	$49.78 +5.1%	$53.00 ➝ $63.00	Equal Weight ➝ Overweight
SMTC Semtech	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Acree Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.60 +21.1%	$82.00 ➝ $68.00	Buy ➝ Buy
SMTC Semtech	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Quinn Bolton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.60 +21.1%	$54.00 ➝ $54.00	Buy ➝ Buy
SMTC Semtech	Target Lowered by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.60 +21.1%	$70.00 ➝ $55.00	Buy
SMTC Semtech	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.60 +21.1%	$60.00 ➝ $54.00	Buy ➝ Buy
SMTC Semtech	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Arcuri Subscribe to MarketBeat All Access for the recommendation accuracy rating	$39.60 +21.1%	$65.00 ➝ $60.00	Buy ➝ Buy
SOL Emeren Group	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Amit Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.19 -19.4%	$7.00 ➝ $7.00	Buy ➝ Buy
SPIR Spire Global	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Austin Moeller Subscribe to MarketBeat All Access for the recommendation accuracy rating	$8.61 -3.0%	$15.00 ➝ $14.50	Buy ➝ Buy
STRO Sutro Biopharma	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tazeen Ahmad Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.81 -35.2%	$11.00 ➝ $1.00	Buy ➝ Underperform
STRO Sutro Biopharma	Downgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.81 -35.2%	$8.00 ➝ $2.00	Outperform ➝ Neutral
STRO Sutro Biopharma	Downgraded by	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Benjamin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.81 -35.2%		Outperform ➝ Market Perform
SUN Sunoco	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Theresa Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.78 +0.6%	$59.00 ➝ $62.00	Overweight ➝ Overweight
DOGE officially begins retirement transformation (Ad) Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retirement" process . This fired the starting gun on the biggest economic transformation in American history. Here's everything you need to do BEFORE Elon has the chance to make his biggest move yet.
TARA Protara Therapeutics	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Li Watsek Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.31 +7.2%		Overweight
TBCH Turtle Beach	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Pachter Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.56 -5.1%	$20.00 ➝ $21.00	Outperform ➝ Outperform
TCRX TScan Therapeutics	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Maxwell Skor Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.74 -2.8%	$10.00	Overweight
TER Teradyne	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the recommendation accuracy rating	$86.74 +1.7%	$112.00 ➝ $81.00	Underweight ➝ Underweight
TLYS Tilly's	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matt Koranda Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.41 -8.7%	$5.00 ➝ $2.50	Neutral ➝ Neutral
TMUS T-Mobile US	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Rollins Subscribe to MarketBeat All Access for the recommendation accuracy rating	$255.98 -1.2%	$268.00	Buy ➝ Neutral
TRML Tourmaline Bio	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.80 +10.3%	$49.00 ➝ $50.00	Buy ➝ Buy
TRML Tourmaline Bio	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.80 +10.3%	$42.00 ➝ $43.00	Outperform ➝ Outperform
TSLA Tesla	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Colin Langan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$249.98 +3.9%	$135.00 ➝ $130.00	Underweight ➝ Underweight
TSVT 2seventy bio	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Matthew Harrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.95	$6.00 ➝ $5.00	Equal Weight ➝ Equal Weight
TTAN ServiceTitan	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.00 +12.9%	$125.00 ➝ $125.00	Buy ➝ Buy
TTAN ServiceTitan	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Josh Baer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.00 +12.9%	$104.00 ➝ $107.00	Equal Weight ➝ Equal Weight
TTAN ServiceTitan	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.00 +12.9%	$125.00 ➝ $125.00	Overweight ➝ Overweight
TTAN ServiceTitan	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.00 +12.9%	$120.00 ➝ $110.00	Buy ➝ Buy
TTAN ServiceTitan	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Kim Subscribe to MarketBeat All Access for the recommendation accuracy rating	$93.00 +12.9%	$105.00 ➝ $90.00	Hold ➝ Hold
ULTA Ulta Beauty	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$475.00 ➝ $380.00	Neutral ➝ Neutral
ULTA Ulta Beauty	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Korinne Wolfmeyer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$425.00 ➝ $364.00	Neutral ➝ Neutral
ULTA Ulta Beauty	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$500.00 ➝ $460.00	Overweight ➝ Overweight
ULTA Ulta Beauty	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Glaessgen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$430.00 ➝ $330.00	Neutral ➝ Neutral
ULTA Ulta Beauty	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mark Astrachan Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$475.00 ➝ $400.00	Hold ➝ Hold
ULTA Ulta Beauty	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$360.00 ➝ $310.00	Underweight ➝ Underweight
ULTA Ulta Beauty	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Horvers Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$480.00 ➝ $475.00	Overweight ➝ Overweight
ULTA Ulta Beauty	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$538.00 ➝ $526.00	Buy ➝ Buy
ULTA Ulta Beauty	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Simeon Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$467.00 ➝ $404.00	Market Perform ➝ Market Perform
ULTA Ulta Beauty	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$510.00 ➝ $415.00	Buy ➝ Buy
ULTA Ulta Beauty	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the recommendation accuracy rating	$357.48 +13.7%	$445.00 ➝ $327.00	Equal Weight ➝ Equal Weight
VIGL Vigil Neuroscience	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.02 -4.3%	$17.00 ➝ $14.00	Buy ➝ Buy
VIGL Vigil Neuroscience	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Laura Chico Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.02 -4.3%	$24.00 ➝ $13.00	Outperform ➝ Outperform
VIK Viking	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Scholes Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.33 +2.9%	$49.00 ➝ $50.00	Hold ➝ Hold
VITL Vital Farms	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Holland Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.94 +5.5%	$44.00 ➝ $42.00	Buy ➝ Buy
VNET VNET Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Louis Tsang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.65 +12.0%	$16.10 ➝ $20.00	Buy ➝ Buy
VNO Vornado Realty Trust	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ronald Kamdem Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.71 +3.7%	$26.00 ➝ $28.00	Equal Weight ➝ Equal Weight
VNO Vornado Realty Trust	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ross Smotrich Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.71 +3.7%	$31.00 ➝ $32.00	Underweight ➝ Underweight
VNOM Viper Energy	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Hanwen Chang Subscribe to MarketBeat All Access for the recommendation accuracy rating	$43.30 +4.4%	$51.00	Overweight
WASH Washington Trust Bancorp	Upgraded by	Seaport Res Ptn Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Hunsicker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.85 +4.8%		Hold ➝ Strong-Buy
WAY Waystar	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.47 +3.4%	$45.00	Buy
WEST Westrock Coffee	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Todd Brooks Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.88 +24.9%	$10.00 ➝ $10.00	Buy ➝ Buy
XPOF Xponential Fitness	Downgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.45 -38.5%	$20.00 ➝ $12.00	Buy ➝ Hold
XPOF Xponential Fitness	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Korinne Wolfmeyer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.45 -38.5%	$16.00 ➝ $9.00	Neutral ➝ Neutral
XPOF Xponential Fitness	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeff Van Sinderen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.45 -38.5%	$12.00 ➝ $9.00	Neutral ➝ Neutral
XPOF Xponential Fitness	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan Meyers Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.45 -38.5%	$20.00 ➝ $16.00	Buy ➝ Buy
XYZ Block	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	$57.18 +5.8%	$108.00 ➝ $90.00	Buy ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:07 AM ET.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Price Targets and Analyst Ratings

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools